American Brain Tumor Association Endurance Team Making Breakthroughs at Chicago Marathon
Chicago, IL (PRWEB) October 11, 2013 -- Team Breakthrough, the American Brain Tumor Association’s running and endurance program, will have 75 runners taking part in the Bank of America Chicago Marathon this Sunday, Oct. 13. In total, ABTA runners have already raised $120,000 in conjunction with this year’s event.
The top three Team Breakthrough Chicago Marathon fundraisers are Curtis Sanford, a brain tumor survivor from Minneapolis; David Turner of Fairfax, Va., running in memory of his mother; and Charlotte Charfen, from Winter Gardens, Fla., running in memory of a friend.
“I am running the Chicago Marathon to show brain tumor survivors, patients and supporters that life does not end with the diagnosis of a brain tumor,” said Sanford. “Though I’m now tumor free, running with Team Breakthrough is a way I can help support research funding and the ABTA’s patient and family support programs.”
ABTA President and CEO Elizabeth M. Wilson praised the efforts of all of this year’s Team Breakthrough runners.
“These incredible athletes not only push themselves to achieve great physical feats by running a marathon, but they push themselves to achieve great fundraising feats in support of the ABTA,” said Wilson. “It is because of their hard work and dedication that the ABTA is fostering breakthroughs in labs and lives all around the country.”
Team Breakthrough allows runners at all levels to support the ABTA's mission through participation in select distance events or an event of their choosing. For more information about 2014 races, visit http://www.abtateambreakthrough.org or call 800-886-1281.
About the American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups. For more information, visit http://www.abta.org.
Kate Butler, ABTA, 773-577-8792, [email protected]
Share this article